PM Modi seeks US investment in India's healthcare sector

23 July 2020

India's Prime Minister Narendra Modi has exhorted US pharmaceutical giants to invest in healthcare. Making a strong pitch on Wednesday for American business to invest in India, Mr Modi emphasized that there was never a better time to invest in a "nation you can trust."

The PM was delivering the keynote address at the US-India Business Council. Stating that India is emerging as a land of opportunity for investors, Mr Modi said the country attracted $20 billion foreign investment amid COVID-19.

"Investment is the best show of confidence. Every year, we are reaching record highs in Foreign Direct Investment," he said, adding that several Council officials had informed that "pledged investment" from the US has already crossed $40 billion this year.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK